Case trackerEmerging

AngioDynamics port claims: who can file and what comes next Updates

Updated Oct 6, 2026

Did your AngioDynamics or Navilyst port break, get infected or cause a blood clot? You may be able to file a claim.

Register interest

Follow the record

No source-linked updates are available here yet. The case guide has the current information and eligibility details.

Read the case guide

Stay informed

Get free updates about AngioDynamics port claims: who can file and what comes next

No phone call required. We will email you about relevant court filings, settlements, or important deadlines.

By submitting, you agree to receive email updates about this case. You can unsubscribe anytime. This is not legal advice, and we are not a law firm.

Sources

  1. JPML Transfer Order, In re AngioDynamics, Inc., and Navilyst Medical, Inc., Port Catheter Products Liability Litigation, MDL No. 3125 (Oct. 3, 2024)JPML transfer order, MDL 3125 · court
  2. JPML, Pending MDL Dockets by Actions Pending (report date Oct. 1, 2026)JPML pending MDL report, Oct. 1, 2026 · court
  3. JPML, Pending MDL Dockets by MDL Number (report date Oct. 1, 2026)JPML pending MDLs by number, Oct. 1, 2026 · court
  4. S.D. Cal., MDL 3125, Stipulated Case Management Order No. 1 (Direct Filing, Service of Process, Attorney Registration), Dkt. 152 (Jan. 27, 2025)MDL 3125 Case Management Order 1 · court
  5. S.D. Cal., MDL 3125, Case Management Order No. 6 (bellwether selection and profile forms), Dkt. 442 (Oct. 14, 2025)MDL 3125 Case Management Order 6 · court
  6. S.D. Cal., MDL 3125, Case Management Order No. 7 (common-issue schedule), Dkt. 466 (Oct. 31, 2025)MDL 3125 Case Management Order 7 · court
  7. S.D. Cal., MDL 3125, Order Granting in Part and Denying in Part Defendants' Motions to Dismiss, Dkt. 239 (Apr. 24, 2025)MDL 3125 order on time-limit motions, Apr. 2025 · court
  8. S.D. Cal., MDL 3125, Order Granting in Part and Denying in Part Defendants' Motions to Dismiss [Dkts. 384, 385], Dkt. 501 (Nov. 14, 2025)MDL 3125 order on time-limit motions, Nov. 2025 · court
  9. S.D. Cal., MDL 3125, Parties' Joint Submission on Proposed Plaintiff Fact Sheet, Dkt. 762 (July 21, 2026)MDL 3125 proposed plaintiff fact sheet · court
  10. S.D. Cal., MDL 3125, Order Setting Briefing Schedule on Motion to Compel, Setting Status Conference, and Governing Discovery Responses, Dkt. 824 (Sept. 22, 2026)MDL 3125 order of Sept. 22, 2026 · court
  11. S.D. Cal., MDL 3125, Case Management Order No. 8 Governing Discovery Process Relating to Plaintiff Profile Forms, Dkt. 573 (Jan. 16, 2026)MDL 3125 Case Management Order 8 · court
  12. CourtListener docket, In re AngioDynamics, Inc., and Navilyst Medical, Inc., Port Catheter Products Liability Litigation, No. 3:24-md-03125 (S.D. Cal.)MDL 3125 docket (CourtListener) · court
  13. Memorandum of Points and Authorities in Support of Defendants AngioDynamics, Inc. and Navilyst Medical, Inc.'s Motion to Dismiss, MDL 3125, Dkt. 194-1 (Feb. 20, 2025)AngioDynamics' motion to dismiss brief · court
  14. FDA Medical Device Recall database: Class 2 Device Recall Vortex MP Port (Z-0132-2023)FDA recall: Vortex MP Port (2022) · regulator
  15. FDA Medical Device Recall database: Class 2 Device Recall Smart Port CT (Z-1466-2021)FDA recall: Smart Port CT (2021) · regulator
  16. FDA Medical Device Recall database: Class 2 Device Recall BioFlo Port with ENDEXO and PASV Technology (Z-0076-2019)FDA recall: BioFlo Port (2018) · regulator
  17. openFDA device recall records for recalling firms AngioDynamics and Navilyst (all 410 product records, queried Oct. 5, 2026)openFDA recall records · regulator
  18. FDA: About Manufacturer and User Facility Device Experience (MAUDE)FDA: About MAUDE · regulator
  19. openFDA device adverse event (MAUDE) records for AngioDynamics or Navilyst, product code LJT (implanted port), counted by brand name (queried Oct. 5, 2026)openFDA adverse event records · regulator
  20. National Cancer Institute, NCI Dictionary of Cancer Terms: portNCI Dictionary: port · regulator
  21. Braun U, et al. Mechanic and surface properties of central-venous port catheters after removal: A comparison of polyurethane and silicon rubber materials. J Mech Behav Biomed Mater. 2016;64:281-91Braun et al., 2016 · study
  22. Wildgruber M, et al. Polyurethane versus silicone catheters for central venous port devices implanted at the forearm. Eur J Cancer. 2016;59:113-124Wildgruber et al., 2016 · study
  23. Surov A, et al. Port catheter insufficiency: incidence and clinical-radiological correlations. Onkologie. 2008;31(8-9):455-61Surov et al., 2008 · study
  24. Goossens GA, et al. Systematic review: malfunction of totally implantable venous access devices in cancer patients. Support Care Cancer. 2011;19(7):883-98Goossens et al., 2011 · study
  25. ABA Model Rule of Professional Conduct 1.5: FeesABA Model Rule 1.5
  26. HHS: Your Medical RecordsHHS: Your Medical Records · regulator
  27. S.D.N.Y. Pro Se FAQ: How long do I have to file my complaint (statute of limitations)?SDNY: filing time limits · court

Want the complete picture?

Read the case guide for eligibility, evidence and your next steps.

View the full AngioDynamics port claims: who can file and what comes next case guide →